Latest funding schemes awardees
13 November 2018
Elizabeth Blackwell Institute runs a number of schemes supporting health related translational projects. Here are details of the latest 2018 awardees at the University of Bristol for two of our translational project funding schemes.
Translational Acceleration and Knowledge Transfer (TRACK) awards
- Andrew Conn (with Co-Investigators Jonathan Rossiter & Marcus Drake)
School of Civil, Aerospace and Mechanical Engineering, 'Active implant to treat stress urinary incontinence'.
- Karim Malik (with Co-Investigators Alexander Greenhough & Ann Williams)
School of Cellular & Molecular Medicine, 'Targeting a hypoxia inducible protein for novel cancer therapies'.
- Ela Chakkarapani
Bristol Medical School, Translational Health Sciences, 'Fetal brain monitoring during intrapartum period: interface development, signal processing and feasibility study'.
- Catherine Morgan
Bristol Medical School, Translational Health Sciences, 'PD SENSORS: Parkinson’s disease Symptom Evaluation in a Naturalistic Setting producing Outcome measuRes using SPHERE '.
About the TRACK scheme
TRACK Awards fund initial pilot studies to demonstrate the concept of a proposed solution to a health, clinical or product development need. These awards support health related research projects which have translational/commercial potential but need to undertake an additional, specific piece of work before seeking proof of concept.
MRC Confidence in Concept (CiC) scheme
- Angela Attwood (with Co-Investigators Chris Jarrold, Sarah Griffiths, Ian Penton-Voak & Marcus Munafo)
School of Psychological Science, 'AboutFace: testing an application to improve emotional face processing in Autism Spectrum Disorder'.
- Raimondo Ascione
Bristol Medical School, Translational Health Sciences, 'Development of a novel polymeric trans-catheter aortic valve to improve durability in high-risk patients: proof of concept study'.
- Moin Saleem
Bristol Medical School, Translational Health Sciences, 'A pathway to full clinical development of the first drug to treat genetic forms of Nephrotic Syndrome'.
- Colin Chu (with Co-Investigators Andrew Dick)
Bristol Medical School, Translational Health Sciences, 'Synthetic Ciliary Body Specific Promoter Design for Viral Gene Therapy for Glaucoma using CRISPR-Cas9'.
- Richard Lee
Bristol Medical School, Translational Health Sciences, 'Selective Calcineurin Inhibition for the Treatment of Steroid Resistant Diseases'.
About the CiC scheme
With support from the MRC these awards fund larger proof of concept studies which provide robust evidence to funders of the feasibility of a proposed solution to a health, clinical or product development need.
They are designed to accelerate the translation of discovery research into new therapies, diagnostics and medical devices by supporting preliminary work or feasibility studies to establish the viability of an approach – before seeking more substantive translational funding.
The Elizabeth Blackwell Institute provides funding to support a range of strategically important research activities across the University of Bristol. Find out about EBI’s funding opportunities.